Cc1ccccc1Cn1nnc2c(O)nc(C3CCCN(C(=O)c4ccc(C(C)(C)C)cc4)C3)nc21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?